These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1215378)

  • 1. The bioavailability of carbamazepine.
    Cotter LM; Smith G; Hooper WD; Tyrer JH; Eadie MJ
    Proc Aust Assoc Neurol; 1975; 12():123-8. PubMed ID: 1215378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavailability of two carbamazepine tablets.
    Glende M; Hüller H; Mai I; Migulla H; Prümke J; Schumann G
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):631-3. PubMed ID: 6668101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and central side effects of different carbamazepine tablets.
    Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):226-32. PubMed ID: 3997307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carbamazepine: the bioavailability of 4 oral pharmaceutical products].
    Saavedra I; Passalacqua A; Chávez H; Biagini L; Galdames D
    Rev Med Chil; 1990 Oct; 118(10):1123-8. PubMed ID: 2152631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the timing of food intake on the absorption and bioavailability of carbamazepine immediate-release tablets in beagle dogs.
    Xu CH; Cheng G; Liu Y; Tian Y; Yan J; Zou MJ
    Biopharm Drug Dispos; 2012 Jan; 33(1):30-8. PubMed ID: 22271001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of food on the bioavailability of a carbamazepine slow-release formulation.
    Retzow A; Schürer M; Schulz HU
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):557-60. PubMed ID: 9455713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation.
    Maas B; Garnett WR; Pellock JM; Comstock TJ
    Ther Drug Monit; 1987; 9(1):28-33. PubMed ID: 3576660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension.
    Bloomer D; Dupuis LL; MacGregor D; Soldin SJ
    Clin Pharm; 1987 Aug; 6(8):646-9. PubMed ID: 3691011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative bioavailability of carbamazepine in 100 mg and 200 mg tablets.
    Smith GA; Hooper WD; Tyrer JH; Eadie MJ; Werth B
    Clin Exp Pharmacol Physiol; 1979; 6(1):37-40. PubMed ID: 761426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative bioavailability and pharmacokinetics of carbamazepine.
    Richter K; Terhaag B
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):377-9. PubMed ID: 689797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and elimination kinetics of carbamazepine in man.
    Rawlins MD; Collste P; Bertilsson L; Palmér L
    Eur J Clin Pharmacol; 1975 Feb; 8(2):91-6. PubMed ID: 1233212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration.
    Wangemann M; Retzow A; Evers G; Mazur D; Schug B; Blume H
    Arzneimittelforschung; 1998 Dec; 48(12):1131-7. PubMed ID: 9893926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of carbamazepine in normal man.
    Levy RH; Pitlick WH; Troupin AS; Green JR; Neal JM
    Clin Pharmacol Ther; 1975 Jun; 17(6):657-68. PubMed ID: 1139857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of DL-oxyfedrine HCl after single-dose oral administration of tablets as compared to equimolar solutions.
    Wetzelsberger N; Birkel M; Fuder H; Lücker PW; Stiegler S; Scheithauer S; Thümmler D
    Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):185-91. PubMed ID: 8531509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
    Hatorp V; Oliver S; Su CA
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.